Petra Trnkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Petra Trnkova has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Markus Stock
MedAustron Ion Therapy Centre, Wiener Neustadt, Austria; Karl Landsteiner University for Health Sciences, Krems, Austria
3 shared publications - Ye Zhang
Center for Proton Therapy Paul Scherrer Institut Villigen Switzerland
3 shared publications - Alessandra Bolsi
Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
2 shared publications Aswin Hoffmann
OncoRay - National Centre for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
2 shared publications- Christian Richter
Oncoray – National Center For Radiation Research In Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
2 shared publications - Emmanuelle Fleury
HollandPTC, Delft, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (22) , 225013
Spot-wise compensation of proton beam deflection and radiation field deformation in the transverse magnetic field of an in-beam MR scanner using a research version of a commercial treatment planning system
Objective . Magnetic resonance-integrated proton therapy (MRiPT) offers the potential for high-precision, image-guided particle therapy but is challenged by magnetic field (MF)-induced proton beam deflection and radiation field deformation. Unless compensated for, these effects compromise dose conformity and prohibit clinical implementation. This work aims to develop and experimentally validate a spot-wise compensation method capable of restoring proton dose distributions in the presence of a measured three-dimensional magnetic vector field map within a clinical treatment planning system (TPS). Approach . A spot-wise compensation framework was implemented in a research version of RayStation, a TPS commercially available for clinical use. The method compensates both lateral beam deflection and MF-induced radiation field deformation by shifting individual pencil-beam spots based on displacement vectors derived from dose calculations in water phantoms using the measured MF of an in-beam MR scanner integrated with a horizontal proton beamline. Two complementary strategies were implemented: a patient-specific approach based on plan-specific displacement calculations, and a generic approach using precomputed displacement maps derived from a reference phantom. Compensation performance was evaluated in representative clinical cases. Dose distributions were experimentally validated using 2D ionisation chamber array measurements. Main results . Both compensation methods effectively restored target coverage, dose homogeneity, and organ-at-risk sparing to the level of no-MF reference plans. The patient-specific method generally achieved a higher performance, whereas the generic compensation method enabled rapid automated correction with sufficient accuracy for clinical workflows involving deep-seated tumours. Local γ -analysis demonstrated excellent agreement between measured and calculated doses, with pass rates exceeding 98.5% for 3%/3 mm criteria. Significance . This work demonstrates that compensation of MF-induced proton beam deflection and field deformation can be achieved entirely within a research version of the RayStation TPS using measured, MR scanner-specific MF data. The proposed method provides a scalable, robust framework for future MRiPT clinical applications.
- 19 November 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (22) , 225013
Open AccessSpot-wise compensation of proton beam deflection and radiation field deformation in the transverse magnetic field of an in-beam MR scanner using a research version of a commercial treatment planning system
Objective . Magnetic resonance-integrated proton therapy (MRiPT) offers the potential for high-precision, image-guided particle therapy but is challenged by magnetic field (MF)-induced proton beam deflection and radiation field deformation. Unless compensated for, these effects compromise dose conformity and prohibit clinical implementation. This work aims to develop and experimentally validate a spot-wise compensation method capable of restoring proton dose distributions in the presence of a measured three-dimensional magnetic vector field map within a clinical treatment planning system (TPS). Approach . A spot-wise compensation framework was implemented in a research version of RayStation, a TPS commercially available for clinical use. The method compensates both lateral beam deflection and MF-induced radiation field deformation by shifting individual pencil-beam spots based on displacement vectors derived from dose calculations in water phantoms using the measured MF of an in-beam MR scanner integrated with a horizontal proton beamline. Two complementary strategies were implemented: a patient-specific approach based on plan-specific displacement calculations, and a generic approach using precomputed displacement maps derived from a reference phantom. Compensation performance was evaluated in representative clinical cases. Dose distributions were experimentally validated using 2D ionisation chamber array measurements. Main results . Both compensation methods effectively restored target coverage, dose homogeneity, and organ-at-risk sparing to the level of no-MF reference plans. The patient-specific method generally achieved a higher performance, whereas the generic compensation method enabled rapid automated correction with sufficient accuracy for clinical workflows involving deep-seated tumours. Local γ -analysis demonstrated excellent agreement between measured and calculated doses, with pass rates exceeding 98.5% for 3%/3 mm criteria. Significance . This work demonstrates that compensation of MF-induced proton beam deflection and field deformation can be achieved entirely within a research version of the RayStation TPS using measured, MR scanner-specific MF data. The proposed method provides a scalable, robust framework for future MRiPT clinical applications.
- Open Access
- 18 September 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 225
Enabling gantry-less radiotherapy through upright patient positioning: Current consensus and future direction
- 18 September 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 225
Open AccessEnabling gantry-less radiotherapy through upright patient positioning: Current consensus and future direction
- 4 July 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111359
Dosimetric verification of every treatment plan: Do or not to do?
- 4 July 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111359
Dosimetric verification of every treatment plan: Do or not to do?
- 13 April 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 219, 111530
Standardizing MRI-only radiotherapy commissioning: Benchmark dataset and acceptance levels from the MESCAL initiative
- 13 April 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 219, 111530
Standardizing MRI-only radiotherapy commissioning: Benchmark dataset and acceptance levels from the MESCAL initiative
- Open Access
- 29 January 2026
- Published by Elsevier in International Journal of Particle Therapy
- Vol. 19, 101300
PTCOG Ocular Survey – Perspective on Ocular Particle Therapy: Current Practices and Emerging Trends
- 29 January 2026
- Published by Elsevier in International Journal of Particle Therapy
- Vol. 19, 101300
Open AccessPTCOG Ocular Survey – Perspective on Ocular Particle Therapy: Current Practices and Emerging Trends
- Open Access
- 9 November 2025
- Published by Elsevier in Physica Medica
- Vol. 140, 105211
Patterns of practice of image guided particle therapy for brain tumours: A site specific multi-institutional survey of the European particle therapy network
- 9 November 2025
- Published by Elsevier in Physica Medica
- Vol. 140, 105211
Open AccessPatterns of practice of image guided particle therapy for brain tumours: A site specific multi-institutional survey of the European particle therapy network
- Open Access
- 28 August 2025
- Published by Elsevier in Physica Medica
- Vol. 137, 105094
Patterns of practice of image guided particle therapy for extremity tumours: A site specific multi-institutional survey of European particle therapy network
- 28 August 2025
- Published by Elsevier in Physica Medica
- Vol. 137, 105094
Open AccessPatterns of practice of image guided particle therapy for extremity tumours: A site specific multi-institutional survey of European particle therapy network
- Open Access
- 12 February 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (4) , 045023
A generalized model for monitor units determination in ocular proton therapy using machine learning: A proof-of-concept study
Objective. Determining and verifying the number of monitor units is crucial to achieving the desired dose distribution in radiotherapy and maintaining treatment efficacy. However, current commercial treatment planning system(s) dedicated to ocular passive eyelines in proton therapy do not provide the number of monitor units for patient-specific plan delivery. Performing specific pre-treatment field measurements, which is time and resource consuming, is usually gold-standard practice. This proof-of-concept study reports on the development of a multi-institutional-based generalized model for monitor units determination in proton therapy for eye melanoma treatments. Approach. To cope with the small number of patients being treated in proton centers, three European institutes participated in this study. Measurements data were collected to address output factor differences across the institutes, especially as function of field size, spread-out Bragg peak modulation width, residual range, and air gap. A generic model for monitor units prediction using a large number of 3748 patients and broad diversity in tumor patterns, was evaluated using six popular machine learning algorithms: (i) decision tree; (ii) random forest, (iii) extra trees, (iv) K-nearest neighbors, (v) gradient boosting, and (vi) the support vector regression. Features used as inputs into each machine learning pipeline were: Spread-out Bragg peak width, range, air gap, fraction and calibration doses. Performance measure was scored using the mean absolute error, which was the difference between predicted and real monitor units, as collected from institutional gold-standard methods. Main results. Predictions across algorithms were accurate within 3% uncertainty for up to 85.2% of the plans and within 10% uncertainty for up to 98.6% of the plans with the extra trees algorithm. Significance. A proof-of-concept of using machine learning-based generic monitor units determination in ocular proton therapy has been demonstrated. This could trigger the development of an independent monitor units calculation tool for clinical use.
- 12 February 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (4) , 045023
Open AccessA generalized model for monitor units determination in ocular proton therapy using machine learning: A proof-of-concept study
Objective. Determining and verifying the number of monitor units is crucial to achieving the desired dose distribution in radiotherapy and maintaining treatment efficacy. However, current commercial treatment planning system(s) dedicated to ocular passive eyelines in proton therapy do not provide the number of monitor units for patient-specific plan delivery. Performing specific pre-treatment field measurements, which is time and resource consuming, is usually gold-standard practice. This proof-of-concept study reports on the development of a multi-institutional-based generalized model for monitor units determination in proton therapy for eye melanoma treatments. Approach. To cope with the small number of patients being treated in proton centers, three European institutes participated in this study. Measurements data were collected to address output factor differences across the institutes, especially as function of field size, spread-out Bragg peak modulation width, residual range, and air gap. A generic model for monitor units prediction using a large number of 3748 patients and broad diversity in tumor patterns, was evaluated using six popular machine learning algorithms: (i) decision tree; (ii) random forest, (iii) extra trees, (iv) K-nearest neighbors, (v) gradient boosting, and (vi) the support vector regression. Features used as inputs into each machine learning pipeline were: Spread-out Bragg peak width, range, air gap, fraction and calibration doses. Performance measure was scored using the mean absolute error, which was the difference between predicted and real monitor units, as collected from institutional gold-standard methods. Main results. Predictions across algorithms were accurate within 3% uncertainty for up to 85.2% of the plans and within 10% uncertainty for up to 98.6% of the plans with the extra trees algorithm. Significance. A proof-of-concept of using machine learning-based generic monitor units determination in ocular proton therapy has been demonstrated. This could trigger the development of an independent monitor units calculation tool for clinical use.
- Open Access
- 17 November 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 28, 100515
Clinical Implementation and Evaluation of Auto-Segmentation Tools for Multi-Site Contouring in Radiotherapy
- 17 November 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 28, 100515
Open AccessClinical Implementation and Evaluation of Auto-Segmentation Tools for Multi-Site Contouring in Radiotherapy